| Fiscal period | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|
| Period End Date | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 |
|---|
| Rental income | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Rental income : Triple-net leased | 622.05 | 619.21 | 598.15 | 653.82 | 695.27 | 780.90 | 737.80 | 840.13 | 845.83 | 779.80 |
| Rental income : Medical office buildings | 874.89 | 867.19 | 801.16 | 794.30 | 799.63 | 828.98 | 776.01 | 753.47 | 630.34 | 566.25 |
| Resident fees and services | 3,372.80 | 2,959.22 | 2,651.89 | 2,270.00 | 2,197.16 | 2,151.53 | 2,069.48 | 1,843.23 | 1,847.31 | 1,811.26 |
| Interest income from loans receivable | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest and other income | 28.11 | 11.41 | 3.64 | 14.81 | 7.61 | 10.98 | 24.89 | 6.03 | 0.88 | 1.05 |
| Gain on sale of Kindred Healthcare, Inc. common stock | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Medical office building services revenue | 17.36 | 17.84 | 26.20 | 20.10 | 15.19 | 11.16 | 13.42 | 13.68 | 21.07 | 41.49 |
| Income from loans and investments | 9.06 | 22.95 | 48.16 | 74.98 | 80.51 | 89.20 | 124.22 | 117.61 | 98.09 | 86.55 |
| Total Revenues | 4,924.27 | 4,497.83 | 4,129.19 | 3,828.01 | 3,795.36 | 3,872.75 | 3,745.81 | 3,574.15 | 3,443.52 | 3,286.40 |
| Rent reset costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Property-level operating expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Medical office buildings | 298.32 | 292.78 | 257.00 | 257.00 | 256.61 | 260.25 | 243.68 | 233.01 | 191.78 | 174.23 |
| Medical office building services costs | 6.51 | 6.10 | 6.19 | 4.43 | 2.32 | 2.32 | 1.42 | 3.39 | 7.31 | 26.57 |
| Property-level operating expenses: Triple-net leased | 15.83 | 14.56 | 15.30 | 15.34 | 22.16 | 26.56 | -- | -- | -- | -- |
| Depreciation and amortization | 1,253.14 | 1,392.46 | 1,197.80 | 1,197.40 | 1,109.76 | 1,045.62 | 919.64 | 887.95 | 898.92 | 894.06 |
| Amortization of restricted stock grants | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock-based compensation | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| General, administrative and professional fees (including non-cash stock-based compensation expense of $1,820 and $727 fo | 162.99 | 148.88 | 144.87 | 129.76 | 130.16 | 166.00 | 151.98 | 135.49 | 126.88 | 128.04 |
| Professional fees | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Senior living | (2,506.41) | (2,247.81) | (2,004.42) | (1,811.73) | (1,658.67) | (1,521.40) | (1,446.20) | (1,250.07) | (1,242.98) | (1,209.42) |
| Litigation proceeds, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest | 602.84 | 574.11 | 467.56 | 440.09 | 469.54 | 451.66 | 442.50 | 448.20 | 419.74 | 367.11 |
| Interest on United States settlement | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Merger-related expenses | (20.37) | (15.22) | (51.58) | (47.32) | (29.81) | (15.24) | (30.55) | (10.54) | (24.64) | (102.94) |
| Net gain on sale of real estate | -- | 29.13 | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss on extinguishment of debt | (0.69) | 6.10 | (0.58) | (59.30) | (10.79) | (41.90) | (58.25) | (0.75) | (2.78) | (14.41) |
| Other | (49.58) | 23.00 | (58.27) | (37.11) | (0.71) | 17.61 | (66.77) | (20.05) | (9.99) | (17.96) |
| Foreign currency gain | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Reversal of contingent liability | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net gain on swap breakage | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net proceeds from litigation settlement | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Contribution to charitable foundation | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss on uncollectible amounts due from tenants | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Swap ineffectiveness | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Allowance on loans receivable and investments | 0.17 | 20.27 | (19.76) | 9.08 | (24.24) | -- | -- | -- | -- | -- |
| Shareholder relations matters | (15.75) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income (loss) before provision (benefit) for income taxes, gain on disposal of real estate assets, discontinued operatio | (8.00) | (115.58) | (94.14) | (162.39) | 80.59 | 359.42 | 384.83 | 584.71 | 518.51 | 351.68 |
| Provision (Benefit) for income taxes | (37.78) | (9.54) | (16.93) | 4.83 | (96.53) | (56.31) | (39.95) | (59.80) | (31.34) | (39.28) |
| Current | 5.60 | 5.69 | -- | -- | -- | 2.61 | 0.27 | (2.25) | (0.68) | -- |
| Deferred | (43.38) | (9.09) | -- | -- | -- | (58.92) | (40.22) | (57.55) | (30.66) | -- |
| Minority interest, net of tax | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss from unconsolidated entities | 1.56 | 13.63 | 28.50 | 4.98 | 1.84 | (2.45) | (55.03) | (0.56) | 4.36 | (1.42) |
| Net loss on real estate disposals | 57.01 | 62.12 | 7.78 | 218.79 | 262.22 | 26.02 | 46.25 | -- | -- | -- |
| Income from continuing operations | -- | (30.30) | (40.93) | 56.56 | 441.19 | 439.30 | 415.99 | 643.95 | 554.21 | 389.54 |
| Discontinued operations | -- | -- | -- | -- | 0.00 | -- | (0.01) | (0.11) | (0.92) | 11.10 |
| Income (loss) before extraordinary loss | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Extroardinary Income (Loss) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain on real estate dispositions | -- | -- | -- | -- | -- | -- | -- | 717.27 | 98.20 | 18.58 |
| Net income (loss) | 88.35 | (30.30) | (40.93) | 56.56 | 441.19 | 439.30 | 415.98 | 1,361.11 | 651.49 | 419.22 |
| Noncontrolling interest, net of tax | 7.20 | 10.68 | 6.52 | 7.55 | 2.04 | 6.28 | 6.51 | 4.64 | 2.26 | 1.38 |
| Preferred stock dividends and issuance costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income(Loss) available to common stockholders | 81.15 | (40.97) | (47.45) | 49.01 | 439.15 | 433.02 | 409.47 | 1,356.47 | 649.23 | 417.84 |
| Income from continuing operations applicable to common shares | 0.21 | (0.08) | (0.10) | 0.15 | 1.18 | 1.20 | 1.17 | 1.81 | 1.88 | 1.23 |
| EPS (Basic) : Income from discontinued operations | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.03 |
| Extraordinary loss on extinguishment of debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | 0.20 | (0.10) | (0.12) | 0.13 | 1.18 | 1.18 | 1.15 | 3.82 | 1.88 | 1.26 |
| Income from continuing operations applicable to common shares | 0.21 | (0.08) | (0.10) | 0.15 | 1.17 | 1.19 | 1.16 | 1.80 | 1.86 | 1.22 |
| EPS (Diluted) : Income from discontinued operations | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.03 |
| Extraordinary loss on extinguishment of debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Diluted) | 0.19 | (0.10) | (0.12) | 0.13 | 1.17 | 1.17 | 1.14 | 3.78 | 1.86 | 1.25 |
| Weighted Average Shares Outstanding (Basic) | 411.77 | 401.81 | 399.55 | 382.79 | 373.37 | 365.98 | 356.27 | 355.33 | 344.70 | 330.31 |
| Weighted Average Shares Outstanding (Diluted) | 416.37 | 405.67 | 403.45 | 386.30 | 376.50 | 369.89 | 359.30 | 358.57 | 348.39 | 334.01 |
| Funds from operations (FFO) | 1,305.45 | 1,321.73 | 1,138.50 | 1,022.77 | 1,269.26 | 1,436.05 | 1,308.15 | 1,512.89 | 1,440.54 | 1,365.41 |